Dr. Lee Kaplan discusses the role of the gastrointestinal tract and gut microbiota in the mechanism of action of bariatric surgery.
Bariatric surgery is one of the most effective treatments of obesity in adults. Unlike many drugs prescribed for the treatment of obesity, bariatric surgery has a broad range of effects, including physiological impact on the gastrointestinal tract and gut microbiota.
In this final installment of our Obesity 2020 webinar series, Dr. Lee Kaplan discusses late-breaking research and reviews various mechanisms of action of bariatric and metabolic surgery and how they affect the regulation of energy balance and metabolic function.
Presenters
Director
Obesity, Metabolism, and Nutrition Institute
Massachusetts General Hospital
Lee M. Kaplan, MD, PhD, is director of the Obesity, Metabolism, and Nutrition Institute and founding director of the Weight Center at Massachusetts General Hospital (MGH), and associate professor of medicine at Harvard Medical School (HMS). His research focuses on the role of the gastrointestinal tract and gut microbiota in the regulation of energy balance and metabolic function, including the mechanism of action of bariatric and metabolic surgery, as well as the genetic determinants of obesity and its response to therapy.
Dr. Kaplan is director of the subspecialty fellowship program in Obesity Medicine and Nutrition at MGH, director of the Blackburn Course in Obesity Medicine at Harvard Medical School, chair of the U.S. Obesity Medicine Fellowship Council, and associate director of the National Institutes of Health (NIH)-sponsored Nutrition and Obesity Research Center at Harvard. He has served in many professional leadership roles and is a past president of The Obesity Society.
Additional Content From American Physiological Society
The Challenges of Sarcopenia: Definition, Underlying Mechanisms, Interventions, and Outcomes
Dr. Charlotte Peterson and Dr. Jack Guralnik will discuss the challenges of sarcopenia. They will define the disease and provide an in depth overview of the underlying mechanisms of pathology. They will then share some potential therapeutic interventions and disease outcomes for patients.
Optogenetic Activation of Selective Cardiac Autonomic Neurons
In this webinar, Dr. Angel Moreno will discuss how optogenetics can be used to modulate the cardiac autonomic system, with a special emphasis on experimental preparation, troubleshooting and data analysis and interpretation.
Conversations Between Mucosal Immunity and the Gut Barrier
Dr. Jerrold Turner discusses the barrier function of the intestine, how the permeability of tight junctions in the gut epithelium is modulated, and the impact of this modulation on homeostasis and health.
Additional Content From The Obesity Society
Anti-Obesity Pharmacotherapy: Where are we now? Where are we going?
OBESITY SERIES 2020: Dr. Ania Jastreboff discusses the current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps.
Related Content
Rodent Models of Pharmacotherapy and Chronotherapy for Obesity and Cardiometabolic Disease
Join Christopher Axelrod and Sander Kooijman, PhD for a discussion on their research into combatting obesity using various new therapies.
Remodeling of Pancreatic Innervation in Diabetes
Dr. Sarah Stanley and Dr. Alexandra Alvarsson discuss the use of whole-organ assessment for the comprehensive examination of pancreatic innervation, revealing close interactions between nerves and islets and dynamic regulation of islet innervation in diabetes.
Ecophysiological Impacts of Climate Change: Performance, Fitness and Extinction
Join Caroline Williams, PhD and Eric Riddell, PhD as they discuss their research involving climate change and the ecophysiological effects of changing global temperatures on organismal biology and survival.